Meeder Asset Management Inc Tg Therapeutics, Inc. Transaction History
Meeder Asset Management Inc
- $1.62 Billion
- Q2 2025
A detailed history of Meeder Asset Management Inc transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Meeder Asset Management Inc holds 50 shares of TGTX stock, worth $1,335. This represents 0.0% of its overall portfolio holdings.
Number of Shares
50
Previous 24,017
99.79%
Holding current value
$1,335
Previous $946,000
99.89%
% of portfolio
0.0%
Previous 0.06%
Shares
12 transactions
Others Institutions Holding TGTX
# of Institutions
415Shares Held
88.5MCall Options Held
2.34MPut Options Held
1.93M-
Vanguard Group Inc Valley Forge, PA15.6MShares$417 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$304 Million0.0% of portfolio
-
State Street Corp Boston, MA7.43MShares$199 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA3.49MShares$93.2 Million0.01% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT2.85MShares$76 Million9.29% of portfolio
About TG THERAPEUTICS, INC.
- Ticker TGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 145,274,000
- Market Cap $3.88B
- Description
- TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...